Quintiliani, Lisa M.
Dedier, Julien
Amezquita, Marislena
Sierra-Ruiz, Melibea
Romero, Dariela
Murillo, Jennifer
Mahar, Sarah
Goodman, Melody
Kane, John B.
Cummings, Doreen
Woolley, Timothy G.
Spinola, Iolando
Crouter, Scott E.
Funding for this research was provided by:
NIH/National Institute on Minority Health & Health Disparities (1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165, 1R01MD015165)
Article History
Received: 21 July 2023
Accepted: 21 August 2023
First Online: 31 August 2023
Declarations
:
: Boston University, Institutional Review Board (IRB), H-42219.Written, informed consent to participate is obtained from all participants. The research study staff member reviews the informed consent document, discuss risks and possible benefits of study participation, answer any questions that arise, and conclude by asking whether they agree to participate. The research study staff member obtains the participant’s signature either in person or when they next meet in person (if done over the telephone). The consent process is the same between English and Spanish-speaking participants. All experimental protocols were approved by Boston University Medical Campus and Boston Medical Center: Institutional Review Board. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: TW is the President of IEQ Technology, Inc., the company that deployed the Phone2Health program described in this study. All other authors declare that they have no conflicts of interests/competing interests.